L Jaszlits

444 total citations
15 papers, 354 citations indexed

About

L Jaszlits is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, L Jaszlits has authored 15 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in L Jaszlits's work include Phenothiazines and Benzothiazines Synthesis and Activities (3 papers), Synthesis and biological activity (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). L Jaszlits is often cited by papers focused on Phenothiazines and Benzothiazines Synthesis and Activities (3 papers), Synthesis and biological activity (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). L Jaszlits collaborates with scholars based in Hungary, Czechia and Italy. L Jaszlits's co-authors include Andrea Jednákovits, Péter Ferdinándy, Zsolt Török, Imre Boros, László Gergely Vigh, Eszter Kovács, Attila Glatz, Bruno Maresca, Gábor Balogh and Kálmán Tory and has published in prestigious journals such as Nature Medicine, Biochemical Pharmacology and European Journal of Medicinal Chemistry.

In The Last Decade

L Jaszlits

15 papers receiving 346 citations

Peers

L Jaszlits

PHYSI

ONCOL

CMN

Joshua D. Bosman United States

Judith K. Woodford United States

Andreas Strub Germany

J. R. Jefferson United States

Ward E. Harris United States

Tetsuo Takagi Japan

Martinus A.M. van Boekel Netherlands

Helen V. Edwards United Kingdom

Bárbara J. Henriques Portugal

María Ángeles Higueras Spain

Joshua D. Bosman United States

L Jaszlits

438 ×1.7

104 ×1.1

50 ×0.9

PHYSI

41 ×0.9

ONCOL

31 ×0.9

CMN

Citations per year, relative to L Jaszlits L Jaszlits (= 1×) peers Joshua D. Bosman

Countries citing papers authored by L Jaszlits

Since Specialization

Citations

This map shows the geographic impact of L Jaszlits's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Jaszlits with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Jaszlits more than expected).

Fields of papers citing papers by L Jaszlits

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Jaszlits. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Jaszlits. The network helps show where L Jaszlits may publish in the future.

Co-authorship network of co-authors of L Jaszlits

This figure shows the co-authorship network connecting the top 25 collaborators of L Jaszlits. A scholar is included among the top collaborators of L Jaszlits based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Jaszlits. L Jaszlits is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Zsuga, Judit, Kálmán Tory, L Jaszlits, et al.. (2004). Pre-clinical methods for the determination of insulin sensitivity. Journal of Biochemical and Biophysical Methods. 61(1-2). 253–258. 1 indexed citations

Rácz, Ildikó, Kálmán Tory, Ferenc Gallyas, et al.. (2002). BGP-15—a novel poly(ADP-ribose) polymerase inhibitor—protects against nephrotoxicity of cisplatin without compromising its antitumor activity. Biochemical Pharmacology. 63(6). 1099–1111. 76 indexed citations

Jednákovits, Andrea, Péter Ferdinándy, L Jaszlits, et al.. (2000). In vivo and in vitro acute cardiovascular effects of bimoclomol. General Pharmacology The Vascular System. 34(5). 363–369. 10 indexed citations

Vigh, László Gergely, Zsolt Török, Gábor Balogh, et al.. (1997). Bimoclomol: A nontoxic, hydroxylamine derivative with stress protein-inducing activity and cytoprotective effects. Nature Medicine. 3(10). 1150–1154. 231 indexed citations

Vigh, László Gergely, Ibolya Horváth, György Tibor Balogh, et al.. (1997). Bimoclomol: a novel, non-toxic, hydroxylamine derivative with stress protein inducing activity and wide cytopretective effects. 3. 1150–1154. 3 indexed citations

Mátyus, Péter, et al.. (1994). Synthesis and Hypotensive Activity of Some Heterocyclic Analogues of GYKI‐12 743. Archiv der Pharmazie. 327(9). 543–546. 1 indexed citations

Mátyus, Péter, et al.. (1992). Synthesis, antihypertensive and α-adrenoceptor activity of novel 2-aminoalkyl-3(2H)-pyridazinones. European Journal of Medicinal Chemistry. 27(2). 107–114. 12 indexed citations

Jaszlits, L, et al.. (1991). Synthesis and hypotensive activity of novel 3-pyridazinyloxypropanolamines. European Journal of Medicinal Chemistry. 26(7). 739–742. 1 indexed citations

Jaszlits, L, et al.. (1991). GYKI-12743 a new postsynaptic vascular alpha-adrenoceptor antagonist.. PubMed. 77(3-4). 257–67. 1 indexed citations

10.

Mátyus, Péter, et al.. (1990). Synthesis and positive inotropic activity of novel pyrimido-[5,4-b][1,4]oxazin-7(8H)-ones. European Journal of Medicinal Chemistry. 25(4). 333–341. 1 indexed citations

11.

Mátyus, Péter, et al.. (1989). GYKI-12743. Drugs of the Future. 14(7). 622–622. 12 indexed citations

12.

Varró, András, M. Kürthy, Ilona Bódi, et al.. (1988). Pharmacology of B-GYKI-38 233 a new antiarrhythmic agent. Pharmacological Research Communications. 20. 71–72. 1 indexed citations

13.

Varró, András, et al.. (1987). Pharmacological investigation of a new anti-arrhythmic agent, GYKI-23 107.. PubMed. 13(1). 21–8. 1 indexed citations

14.

Jaszlits, L, et al.. (1982). Cardiovascular effects of a potent opioid peptide, (D-Met2, Pro5)-enkephalinamide.. PubMed. 260(1). 91–103. 2 indexed citations

15.

Szilágyi, G., et al.. (1980). ChemInform Abstract: STUDIES IN THE FIELD OF PYRIDAZINE COMPOUNDS, III (1). HYPOTENSIVE 3‐(1‐PYRAZOLYL) PYRIDAZINE DERIVATIVES. Chemischer Informationsdienst. 11(11). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact